Abstract
A highly sensitive and well-reproducible HPLC procedure has been developed for the quantitative determination of fexofenadine in the blood plasma. The drug was separated by reverse-phase HPLC on a μ-Bondapak Phenyl column and reliably detected by spectrophotometry at 220 nm.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
